Chronic fatigue syndrome

Fatigue Science for Human Health

Volumn , Issue , 2008, Pages 67-88

  Kuratsune, Hirohiko ^a   Watanabe, Yasuyoshi ^b  

^a KANSAI UNIVERSITY OF WELFARE SCIENCES   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892022959     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-4-431-73464-2_6     Document Type: Chapter

References (51)

1. Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Strauss SE, Jones JF, Dubois RE, Cunningham-Rundles C, Pahwa S, Tosato G, Zegans LS, Purtilo DT, Browh N, Schooles RT, Brus I (1988) Chronic fatigue syndrome: A working case definition. Ann Intern Med 108:387-389.
2. Holmes TH, Rahe RH (1967) The social readjustment rating scale. J Psychosom Res 11:213-218.
3. Narita M, Nishigami N, Narita N, Yamaguti K, Okado N, Watanabe Y, Kuratsune H (2003) Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochem Biophys Res Commun 311(2):264-266.
4. Klimas NG, Salvato FR, Morgan R, Fletcher MA (1990) Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 28(6):1403-1410.
5. Bennett AL, Chao CC, Hu S, Buchwald D, Fagioli LR, Schur PH, Peterson PK, Komaroff AL (1997) Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome. J Clin Immunol 17(2):160-166.
6. Moss RB, Mercandetti A, Vojdani A (1999) TNF-alpha and chronic fatigue syndrome. J Clin Immunol 19(5):314-316.
7. Suhadolnik RJ, Reichenbach NL, Hitzges P, Sobol RW, Peterson DL, Henry B, Ablashi DV, Müller WE, Schröder HC, Carter WA, Strayer DR (1994) Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis 18(Suppl 1):S96-S104.
8. Ikuta I, Yamada T, Shimomura T, Kuratsune H, Kawahara R, Ikawa S, Ohnishi E, Sokawa Y, Fukushi H, Hirai K, Watanabe Y, Kurata T, Kitani T, Sairenji T (2003) Diagnostic evaluation for 2′, 5′-oligoadenylate synthetase activities and antibodies against Epstein-Barr virus and Coxiella burnetii in patients with chronic fatigue syndrome in Japan. Microbes Infect 5(12):1096-1102.
9. Demettre E, Bastide L, D'Haese A, De Smet K, De Meirleir K, Tiev KP, Englebienne P, Lebleu B (2002) Ribonuclease L proteolysis in peripheral blood mononuclear cells of chronic fatigue syndrome patients. J Biol Chem 277(38):35746-35751.
10. Katafuchi T, Kondo T, Yasaka T, Kubo K, Take S, Yoshimura M (2003) Prolonged effects of polyriboinosinic:polyribocytidylic acid on spontaneous running-wheel activity and brain interferon-alpha mRNA in rats: A model for immunologically induced fatigue. Neuroscience 120(3):837-845.
11. Inoue K, Yamazaki H, Manabe Y, Fukuda C, Hanai K, Fushiki T (1999) Transforming growth factor-beta activated during exercise in brain depresses spontaneous motor activity of animals. Relevance to central fatigue. Brain Res 846(2):145-153.
12. Stankovic AK, Dion LD, Parker CR Jr. (1994) Effects of transforming growth factor-beta on human fetal adrenal steroid production. Mol Cell Endocrinol 99(2):145-151.
13. Chiu KM, Schmidt MJ, Shug AL, Binkley N, Gravenstein S (1997) Effect of dehydroepiandrosterone sulfate on carnitine acetyl transferase activity and L-carnitine levels in oophorectomized rats. Biochim Biophys Acta 1344(3):201-209.
14. Kuratsune H, Yamaguti K, Sawada M, Kodate S, Machii T, Kanakura Y, Kitani T (1998) Dehydroepiandrosterone sulfate defi ciency in chronic fatigue syndrome. Int J Mol Med 1:143-146.
15. Kuratsune H, Yamaguti K, Takahashi M, Misaki H, Tagawa S, Kitani T (1994) Acylcarnitine defi ciency in chronic fatigue syndrome. Clin Infect Dis 18(Suppl 1):S62-S67.
16. Tanaka S, Kuratsune H, Hidaka Y, Hakariya Y, Tatsumi KI, Takano T, Kanakura Y, Amino N (2003) Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome. Int J Mol Med 12:225-230.
17. Levy JA (1994) Viral studies of chronic fatigue syndrome. Clin Infect Dis 18(Suppl 1): S117-S120.
18. Ablashi DV, Eastman HB, Owen CB, Roman MM, Friedman J, Zabriskie JB, Peterson DL, Pearson GR, Whitman JE (2000) Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol 16(3):179-191.
19. Vojdani A, Choppa PC, Tagle C, Andrin R, Samimi B, Lapp CW (1998) Detection of Mycoplasma genus and Mycoplasma fermentans by PCR in patients with chronic fatigue syndrome. FEMS Immunol Med Microbiol 22(4):355-365.
20. Nakaya T, Takahashi H, Nakamura Y, Asahi S, Tobiume M, Kuratsune H, Kitani T, Yamanishi K, Ikuta K (1996) Demonstration of Borna disease virus RNA in peripheral blood mononuclear cells derived from Japanese patients with chronic fatigue syndrome. FEBS Lett 378:145-149.
21. Nakaya T, Takahashi H, Nakamur Y, Kuratsune H, Kitani T, Machii T, Yamanishi K, Ikuta K (1999) Borna disease virus infection in two family clusters of patients with chronic fatigue syndrome. Microbiol Immunol 43(7):679-689.
22. Evengård B, Briese T, Lindh G, Lee S, Lipkin WI (1999) Absence of evidence of Borna disease virus infection in Swedish patients with chronic fatigue syndrome. J Neurovirol 5(5):495-499.
23. Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJ, Chrousos GP, Gold PW (1991) Evidence for impaired activation of the hypothalamic- pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 73(6):1224-1234.
24. Roberts AD, Wessely S, Chalder T, Papadopoulos A, Cleare AJ (2004) Salivary cortisol response to awakening in chronic fatigue syndrome. Br J Psychiatr 184:136-131.
25. Gaab J, Engert V, Heitz V, Schad T, Schürmeyer TH, Ehlert U (2004) Associations between neuroendocrine responses to the insulin tolerance test and patient characteristics in chronic fatigue syndrome. J Psychosom Res 56(4):419-424.
26. Gaab J, Hüster D, Peisen R, Engert V, Schad T, Schürmeyer TH, Ehlert U (2002) Low-dose dexamethasone suppression test in chronic fatigue syndrome and health. Psychosom Med 64(2):311-318.
27. Rebouche CJ (1988) Carnitine metabolism and human nutrition. J Appl Nutr 40:99-111.
28. Yamaguti K, Kuratsune H, Watanabe Y, Takahashi M, Nakamoto I, Machii T, Jacobsson G, Onoe H, Matsumura K, Valind S, Langstrom B, Kitani T (1996) Acylcarnitine metabolism during fasting and after refeeding. Biochem Biophys Res Commun 225:740-746.
29. Kuratsune H, Yamaguti K, Lindh G, Evengård B, Hagberg G, Matsumura K, Iwase M, Onoe H, Takahashi M, Machii T, Kanakura Y, Kitani T, Långström B, Watanabe Y (2002) Brain regions involved in fatigue sensation: reduced acetylcarnitine uptake into the brain. Neuroimage 17(3):1256-1265.
30. Plioplys AV, Plioplys S (1995) Serum levels of carnitine in chronic fatigue syndrome: clinical correlates. Biol Psychiatr 32:132-138.
31. Soetekouw PM, Wevers RA, Vreken P, Elving LD, Janssen AJ, van der Veen Y, Bleijenberg G, van der Meer JW (2000) Normal carnitine levels in patients with chronic fatigue syndrome. Neth J Med 57(1):20-24.
32. Jones MG, Goodwin CS, Amjad S, Chalmers RA (2005) Plasma and urinary carnitine and acylcarnitines in chronic fatigue syndrome. Clin Chim Acta 360(1-2):173-177.
33. Vermeulen RC, Scholte HR (2006) Azithromycin in chronic fatigue syndrome (CFS): An analysis of clinical data. J Trans Med 4:34.
34. Vermeulen RC, Scholte HR (2004) Exploratory open label, randomized study of acetyl- And propionylcarnitine in chronic fatigue syndrome. Psychosom Med 66(2):276-282.
35. Kuratsune H, Yamaguti K, Watanabe Y, Takahashi M, Nakamoto I, Machii T, Jacobson GB, Onoe H, Matsumura T, Valind S, Langstrom B, Kitani T (1997) Acylcarnitine and chronic fatigue syndrome. In: DeSimone C, Famularo G (eds) Carnitine today. Molecular Biology Intelligence Unit, Landes Bioscience, pp 195-213.
36. Natelson BH, Cohen JM, Brassloff I, Lee HJ (1993) A controlled study of brain magnetic resonance imaging in patients with the chronic fatigue syndrome. J Neurol Sci 120(2):213-217.
37. Greco A, Tannock C, Brostoff J, Costa DC (1997) Brain MR in chronic fatigue syndrome. Am J Neuroradiol 18(7):1265-1269.
38. Lange G, DeLuca J, Maldjian JA, Lee H, Tiersky LA, Natelson BH (1999) Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome. J Neurol Sci 171(1):1-2.
39. Cook DB, Lange G, DeLuca J, Natelson BH (2001) Relationship of brain MRI abnormalities and physical functional status in chronic fatigue syndrome. Int J Neurosci 107(1-2):1-6.
40. Okada T, Tanaka M, Kuratsune H, Watanabe Y, Sadato N (2004) Mechanisms underlying fatigue: A voxel-based morphometric study of chronic fatigue syndrome. BMC Neurol 4(1):14.
41. de Lange FP, Kalkman JS, Bleijenberg G, Hagoort P, van der Meer JW, Toni I (2005) Gray matter volume reduction in chronic fatigue syndrome. Neuroimage 26(3):777-781.
42. Ichise M, Salit IE, Abbey SE, Chung DG, Gray B, Kirsh JC, Freedman M (1992) Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome. Nucl Med Commun 13:767-772.
43. Costa DC, Tannock C, Brostoff J (1995) Brainstem perfusion is impaired in chronic fatigue syndrome. QJM 88:767-773.
44. Fischler B, D'Haenen H, Cluydts R, Michiels V, Demets K, Bossuyt A, Kaufman L, De Meirleir K (1996) Comparison of 99m Tc HMPAO SPECT scan between chronic fatigue syndrome, major depression and healthy controls: An exploratory study of clinical correlates of regional cerebral blood flow. Neuropsychobiology 34:175-183.
45. Tirelli U, Chierichetti F, Tavio M, Simonelli C, Bianchin G, Zanco P, Ferlin G (1998) Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. Am J Med 105(3A):54S-58S.
46. Siessmeier T, Nix WA, Hardt J, Schreckenberger M, Egle UT, Bartenstein P (2003) Observerindependent analysis of cerebral glucose metabolism in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 74(7):922-928.
47. Yamamoto S, Ouchi Y, Onoe H, Yoshikawa E, Tsukada H, Takahashi H, Iwase M, Yamaguti K, Kuratsune H, Watanabe Y (2004) Reduction of serotonin transporters in patients with chronic fatigue syndrome. Neuroreport 15:2571-2574.
48. Demettre E, Bastide L, D'Haese A, De Smet K, De Meirleir K, Tiev KP, Englebienne P, Lebleu B (2002) Ribonuclease L proteolysis in peripheral blood mononuclear cells of chronic fatigue syndrome patients. J Biol Chem 277(38):35746-35751.
49. Oliff A, Defeo-Jones D, Boyer M, Martinez D, Kiefer D, Vuocolo G, Wolfe A, Socher SH (1987) Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 50(4):555-563.
50. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A (1994) The chronic fatigue syndrome: A comprehensive approach to its defi nition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 121(12):953-959.
51. Bode L, Dietrich DE, Stoyloff R, Emrich HM, Ludwig H (1997) Amantadine and human Borna disease virus in vitro and in vivo in an infected patient with bipolar depression. Lancet 349(9046):178-179.